Modulating ROS to overcome multidrug resistance in cancer

Q Cui, JQ Wang, YG Assaraf, L Ren, P Gupta… - Drug Resistance …, 2018 - Elsevier
The successful treatment of cancer has significantly improved as a result of targeted therapy
and immunotherapy. However, during chemotherapy, cancer cells evolve and can acquire …

[HTML][HTML] A non-proliferative role of pyrimidine metabolism in cancer

A Siddiqui, P Ceppi - Molecular metabolism, 2020 - Elsevier
Background Nucleotide metabolism is a critical pathway that generates purine and
pyrimidine molecules for DNA replication, RNA synthesis, and cellular bioenergetics …

Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics

RH Wijdeven, B Pang, YG Assaraf, J Neefjes - Drug Resistance Updates, 2016 - Elsevier
Efficacy of chemotherapy in the treatment of distinct malignancies is often hampered by drug
resistance arising in the tumor. Understanding the molecular basis of drug resistance and …

Repurposing old drugs to fight multidrug resistant cancers

J Dinić, T Efferth, AT García-Sosa, J Grahovac… - Drug Resistance …, 2020 - Elsevier
Overcoming multidrug resistance represents a major challenge for cancer treatment. In the
search for new chemotherapeutics to treat malignant diseases, drug repurposing gained a …

Chemotherapy resistance: Role of mitochondrial and autophagic components

E Bahar, SY Han, JY Kim, H Yoon - Cancers, 2022 - mdpi.com
Simple Summary Chemotherapy resistance is a common occurrence during cancer
treatment that cancer researchers are attempting to understand and overcome. Mitochondria …

[HTML][HTML] Emerging roles of F-box proteins in cancer drug resistance

L Yan, M Lin, S Pan, YG Assaraf, Z Wang… - Drug Resistance Updates, 2020 - Elsevier
Chemotherapy continues to be a major treatment strategy for various human malignancies.
However, the frequent emergence of chemoresistance compromises chemotherapy efficacy …

[HTML][HTML] FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis

Y Li, J Chen, B Wang, Z Xu, C Wu, J Ma, Q Song… - Drug Resistance …, 2023 - Elsevier
Aims Nucleotide de novo synthesis is essential to cell growth and survival, and its
dysregulation leads to cancers and drug resistance. However, how this pathway is …

Anticancer Activity of a Hexapeptide from Skate (Raja porosa) Cartilage Protein Hydrolysate in HeLa Cells

X Pan, YQ Zhao, FY Hu, CF Chi, B Wang - Marine Drugs, 2016 - mdpi.com
In this study, the hexapeptide Phe-Ile-Met-Gly-Pro-Tyr (FIMGPY), which has a molecular
weight of 726.9 Da, was separated from skate (Raja porosa) cartilage protein hydrolysate …

Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth

L Costantino, S Ferrari, M Santucci, OMH Salo-Ahen… - Elife, 2022 - elifesciences.org
Drugs that target human thymidylate synthase (hTS), a dimeric enzyme, are widely used in
anticancer therapy. However, treatment with classical substrate-site-directed TS inhibitors …

Molecular research in pancreatic cancer: Small molecule inhibitors, their mechanistic pathways and beyond

SA Shetu, N James, G Rivera… - Current Issues in …, 2023 - mdpi.com
Pancreatic enzymes assist metabolic digestion, and hormones like insulin and glucagon
play a critical role in maintaining our blood sugar levels. A malignant pancreas is incapable …